Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors (vol 12, 2016, 2021)

被引：4

作者：

Iketani, Sho

Forouhar, Farhad

Liu, Hengrui

Hong, Seo Jung

Lin, Fang-Yu

Nair, Manoj S.

Zask, Arie

Huang, Yaoxing

Xing, Li

Stockwell, Brent R.

Chavez, Alejandro

Ho, David D.

机构：

[1] Aaron Diamond AIDS Research Center, Columbia University Irving Medical Center, New York, NY

[2] Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY

[3] Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY

[4] Department of Chemistry, Columbia University, New York, NY

[5] Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY

[6] WuXi AppTec, Cambridge, MA

[7] Department of Biological Sciences, Columbia University, New York, NY

来源：

NATURE COMMUNICATIONS | 2021年 / 12卷 / 01期

基金：

美国国家卫生研究院;

关键词：

D O I：

10.1038/s41467-021-23082-3

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

We report the identification of three structurally diverse compounds – compound 4, GC376, and MAC-5576 – as inhibitors of the SARS-CoV-2 3CL protease. Structures of each of these compounds in complex with the protease revealed strategies for further development, as well as general principles for designing SARS-CoV-2 3CL protease inhibitors. These compounds may therefore serve as leads for the basis of building effective SARS-CoV-2 3CL protease inhibitors. © 2021, The Author(s).

引用

页数：1

共 50 条

[11] In-silico approaches for identification of compounds inhibiting SARS-CoV-2 3CL protease
Zeyaullah, Md. M.
Khan, Nida
Muzammil, Khursheed
AlShahrani, Abdullah
Khan, Mohammad Suhail
Alam, Md. Shane A.
Ahmad, Razi A.
Khan, Wajihul Hasan A.
PLOS ONE, 2023, 18 (04):
[12] Virtual Screening of Chinese Medicine Small Molecule Compounds Targeting SARS-CoV-2 3CL Protease (3CL pro)
He, Qingxiu
Chen, Xin
Yang, Xi
Li, Guangpin
Gu, Haiqiong
Chu, Han
Lin, Zhihua
Wang, Yuanqiang
LETTERS IN DRUG DESIGN & DISCOVERY, 2021, 18 (04) : 355 - 364
[13] Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-Throughput Screening
Zhu, Wei
Xu, Miao
Chen, Catherine Z.
Guo, Hui
Shen, Min
Hu, Xin
Shinn, Paul
Klumpp-Thomas, Carleen
Michael, Samuel G.
Zheng, Wei
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2020, 3 (05) : 1008 - 1016
[14] Capillary electrokinetic chromatography for chiral separation of potential SARS-CoV-2 3CL protease inhibitors
Brier, Lucile
Furman, Christophe
Charton, Julie
Deprez, Benoit
Lipka, Emmanuelle
ELECTROPHORESIS, 2024, 45 (11-12) : 1010 - 1017
[15] Evaluation of metal-conjugated compounds as inhibitors of 3CL protease of SARS-CoV
Hsu, JTA
Kuo, CJ
Hsieh, HP
Wang, YC
Huang, KK
Lin, CPC
Huang, PF
Chen, X
Liang, PH
FEBS LETTERS, 2004, 574 (1-3): : 116 - 120
[16] In silico screening-based discovery of novel covalent inhibitors of the SARS-CoV-2 3CL protease
Xiong, Muya
Nie, Tianqing
Shao, Qiang
Li, Minjun
Su, Haixia
Xu, Yechun
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 231
[17] Biochemical and structural characterization of second-generation inhibitors targeting the SARS-CoV-2 3CL protease
Muczynski, Michael
Engel, Joseph
Amblard, Franck
Patel, Dharmeshkumar
Schinazi, Raymond
Kovari, Ladislau
JOURNAL OF BIOLOGICAL CHEMISTRY, 2024, 300 (03) : S180 - S180
[18] Efficacy comparison of 3CL protease inhibitors ensitrelvir and nirmatrelvir against SARS-CoV-2 in vitro and in vivo
Kuroda, Takayuki
Nobori, Haruaki
Fukao, Keita
Baba, Kaoru
Matsumoto, Kazumi
Yoshida, Shinpei
Tanaka, Yukari
Watari, Ryosuke
Oka, Ryoko
Kasai, Yasuyuki
Inoue, Kae
Kawashima, Sho
Shimba, Alice
Hayasaki-Kajiwara, Yoko
Tanimura, Miki
Zhang, Qianhui
Tachibana, Yuki
Kato, Teruhisa
Shishido, Takao
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2023, 78 (04) : 946 - 952
[19] Synthesis and SARS-CoV-2 3CL Protease Inhibitory Effects of Oxazolidinone Derivatives
Zhao, Shengxian
Wang, Chaojie
Lu, Yiming
Zhang, Xin
Wu, Siyu
Mao, Hui
JOURNAL OF THE BRAZILIAN CHEMICAL SOCIETY, 2022, 33 (09) : 1134 - 1143
[20] Binding and Unbinding Pathways of Peptide Substrates on the SARS-CoV-2 3CL Protease
Moritsugu, Kei
Ekimoto, Toru
Ikeguchi, Mitsunori
Kidera, Akinori
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2023, 63 (01) : 240 - 250

← 1 2 3 4 5 →